Stock Market News for December 10, 2025
555 news published.
Market-moving deals and listings
Willis Towers Watson (WTW) remains in focus as it advances two strategic deals—the planned acquisition of Newfront and the purchase of UK fintech pensions provider Cushon—moves that expand distribution and digital capabilities and will be watched for margin and integration risk.
Earnings, offerings and financings
Adobe (ADBE) reported record Q4 and FY2025 revenue, a sizable top‑line beat that keeps the software subscription narrative intact.
Oracle (ORCL) posted FY2026 Q2 results, another data point on enterprise cloud spending that investors use to judge tech budgets.
Synopsys (SNPS) delivered Q4 and FY2025 results, relevant for chip‑design software demand amid semiconductor cycle signals.
Pure Storage (PSTG) authorized a $400 million share buyback, a capital‑return that supports EPS as AI workloads continue to drive storage demand.
T1 Energy (TE) unveiled proposed concurrent offerings of convertible senior notes due 2030 and common stock—moves that will shape leverage and dilution scenarios for investors. Read the filing.
Ur‑Energy (URG) launched a proposed $100 million convertible note offering to fund uranium project development—watch funding milestones and project timelines.
Share repurchases and capital returns
Azenta (AZTA) authorized a $250 million buyback, a material program that could bolster per‑share metrics if deployed.
Technology, AI and datacenter optics
AOI (AAOI) received its first volume order for 800G data‑center transceivers from a major hyperscale customer—an important validation for optics suppliers as cloud providers upgrade bandwidth.
C3 AI (AI) was named a leader in a major AI platforms study, a reputational boost that could smooth enterprise sales cycles. See the report.
CrowdStrike (CRWD) scored 100% detection and 100% protection in MITRE ATT&CK® Enterprise evaluations, reinforcing endpoint leadership.
TD SYNNEX (SNX) released an AI game plan to help partners scale customer AI adoption—an ecosystem play aimed at lifting services and systems integration revenue. Read the plan.
DXC (DXC) launched AdvisoryX and published insights on the AI execution gap, positioning for higher‑margin transformation work. See the announcement.
Energy, industrials and infrastructure
Eaton (ETN) is investing $50M+ in a Virginia facility to advance grid‑to‑chip AI data‑center solutions—tying power management to AI infrastructure demand.
USA Rare Earth (USAR) accelerated commercial production at Round Top by two years, shifting supply expectations for rare‑earths used in clean energy and defense. Read the update.
NOV (NOV) announced the sale of Advanced Nuclear developer Shepherd Power to Natura Resources in a stock‑for‑stock deal and will partner to deploy gigawatts of SMRs in the early 2030s—an industrial pivot toward nuclear services with long‑dated revenue optionality. Read the transaction notice.
AMSC (AMSC) expanded its product portfolio and entered Brazil with the Comtrafo acquisition, accelerating its grid and power‑electronics footprint in key markets.
Nordson (NDSN) reported record Q4 and FY2025 results, a clear industrial signal for durable‑goods demand and margin execution.
Gran Tierra Energy (GTE) provided 2026 guidance and an operations update, offering a view into exploration plans and cash‑flow expectations that matter for oil‑and‑gas investors watching capital discipline and commodity sensitivity.
Biotech, clinical data and regulatory updates
Pfizer (PFE) announced TUKYSA added to first‑line maintenance therapy, extending median PFS by over eight months in HER2+ metastatic breast cancer—an approval with commercial and clinical implications.
GRI Bio (GRI) reported positive topline Phase 2a IPF data, an important milestone that could attract licensing interest.
Serina Therapeutics (SER) submitted a complete response to an FDA clinical‑hold letter for its SER‑252 program—investors will watch the agency's feedback for trial restart timing and value inflection.
InfuSystem (INFU) said ambulatory infusion pumps used in its pain‑management business will receive separate payment under the NOPAIN Act starting Jan. 1, 2026. That reimbursement shift can lift revenue visibility and margins for device rentals tied to outpatient pain care.
NovaBridge (NBP) presented positive Phase 1 dose‑expansion data for ragistomig at ESMO‑IO—early efficacy that could influence partnership conversations.
Aardvark Therapeutics (AARD) dosed the first patient in Australia in the HERO Phase 3 trial for Prader‑Willi, a trial start that complements upcoming data from Rhythm and matters for competitive positioning in rare disease therapies. Read the notice.
Space, defense and aerospace wins
Momentus (MNTS) was selected for a U.S. Space Force SHIELD contract vehicle and announced a warrant inducement expected to raise about $3.7 million, opening programmatic revenue channels.
Voyager (VOYG) won a $21 million contract to advance airborne mission capabilities—a near‑term revenue boost and validation for its mission systems roadmap. Details here.
Payments, credit and fintech
TransUnion (TRU) released its 2026 outlook calling for moderate credit‑card balance growth and stable delinquencies—a consumer‑credit read that helps shape lender loss assumptions.
Fifth Third Bank (FITB) said it will decrease its prime lending rate to 6.75%, a competitive repricing that could influence loan margins and local deposit pricing dynamics. Read the announcement.
Gemini (GEMI) received a U.S. license for prediction markets, a regulatory win that opens new product rails and could expand crypto‑native revenue streams.
Corporate strategy, M&A and governance
Darling Ingredients (DAR) and Tessenderlo Group signed a definitive agreement to form a new company focused on collagen‑based health and nutrition—an M&A move that accelerates entry into higher‑growth food‑tech markets.
SMX (SMX) amended its equity purchase agreement while presenting a BFR sorting solution to trade groups—actions that shore up a transformative deal and highlight licensing potential. Read the takeaways.
The Baldwin Group (BWIN) priced a $600 million Term Loan B add‑on, improving liquidity to support larger contract bids. See the filing.
Granite Real Estate Investment Trust (GRP) announced its intention to voluntarily delist from the NYSE and deregister with the SEC. That move changes liquidity and reporting dynamics for holders and can prompt re‑rating among REIT investors focused on governance and access to public markets.
Listings, financings and exchanges
TenX Protocols (DEFT), a DeFi Technologies advisory client and venture investment, debuted on the TSX Venture Exchange as "TNX" following a successful $30 million financing—a noteworthy capital market event in digital assets.
Figure (FIGR) brought $YLDS to Solana, a move that unlocks real‑world‑asset utility for DeFi and signals ongoing tokenization experiments that investors will watch for adoption and regulatory scrutiny.
What to watch next
Track WTW’s integration risks and margin trajectory from its two deals. Watch Adobe, Oracle and Synopsys for trends in enterprise cloud and semiconductor tool spending. In tech, AAOI’s 800G win and Pure Storage’s buyback are useful signals on datacenter capex and supplier validation. For industrials and energy, NOV’s Shepherd Power sale and partnership on SMRs, alongside Nordson’s record results and Eaton’s Virginia investment, will be parsed for long‑term revenue streams and capital intensity. In healthcare, InfuSystem’s NOPAIN Act reimbursement change and Serina’s FDA response are near‑term catalysts. Finally, monitor Granite REIT’s delisting for liquidity implications and Figure’s Solana rollout as a barometer of institutional interest in tokenized RWA in crypto markets.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement